Browse the evidence

Patients with persistent complete concentric velopharyngeal collapse in the supine position had a mean apnea–hypopnea index (AHI) of 54.7 events/h, significantly higher than the 60 patients without such collapse in position 4, who had a mean AHI of 35.5 events/h.

Clinicians should consider the severity of velopharyngeal collapse when assessing sleep apnea treatment options.

The study demonstrated the feasibility, safety, and usefulness of using a simple edge‐to‐edge, reusable oral appliance in drug-induced sleep endoscopy.

Oral appliances may be a viable option for patients undergoing sleep apnea evaluation.

Bioactive compounds affect appetite regulation through the central nervous system, peripheral hormones, and intestinal microbiota.

Practitioners should consider multiple pathways when addressing appetite regulation.

Higher psychosocial stress is significantly associated with increased risk of death, cardiovascular disease (CVD), coronary heart disease (CHD), and stroke events.

Practitioners should consider psychosocial stress as a significant factor in assessing cardiovascular risk.

High stress is associated with a higher risk of coronary heart disease (CHD) and stroke compared to no stress.

High stress levels should be addressed in patients to mitigate risks of CHD and stroke.

As the level of psychosocial stress increases, the risk of death and coronary heart disease also increases.

Monitoring and managing stress levels may be crucial for reducing mortality and CHD risk.

The proposed wireless acquisition system for grip force monitoring demonstrates excellent performance in real-time signal acquisition and grip force prediction.

Practitioners can utilize this system for effective muscle monitoring in various applications.

The grip force prediction model established using dual-channel sEMG signals achieved an R2 of 0.9215.

This high R2 value indicates reliable grip force predictions, useful for training and rehabilitation.

The system is characterized as portable, wearable, low-cost, and easy to operate.

The system's design makes it accessible for various users in fitness and rehabilitation settings.

Probability of mild cognitive impairment (MCI) or probable dementia (PD) differed by type 2 diabetes (T2D) subgroup.

Healthcare providers should consider T2D subgroup characteristics when assessing cognitive health risks.

The highest probability of MCI/PD was found in the T2D subgroup characterized by severe obesity.

Focus on weight management strategies in T2D patients to mitigate cognitive decline risks.

Performance of the Roman Chair Back Extension may increase the risk for low back pain among certain population subgroups.

Practitioners should assess individual risk factors before recommending this exercise.

The incidence of peripheral neuropathy (PN) differs by type 2 diabetes (T2D) subgroup.

Healthcare providers should consider T2D subgroups when assessing PN risk.

GLP1-RA treatment is not associated with a significant difference in risk of serious psychiatric adverse events compared with placebo (log[RR] = -0.02; P = .87).

GLP1-RAs can be considered safe regarding serious psychiatric events in this population.

Hypothalamic inflammation and gliosis are present in children and adults with obesity.

Practitioners should consider hypothalamic inflammation as a factor in obesity management.

Patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) with a hazard ratio of 1.76.

Clinicians should monitor patients on semaglutide or tirzepatide for signs of NAION.

Patients prescribed semaglutide or tirzepatide had an increased risk of other optic nerve disorders with a hazard ratio of 1.65.

Clinicians should be aware of the risk of other optic nerve disorders in patients on semaglutide or tirzepatide.

Continuous positive airway pressure therapy is the most widely prescribed treatment for obstructive sleep apnea.

Clinicians should consider CPAP as a first-line treatment for patients with obstructive sleep apnea.

Understanding the pathophysiological traits of OSA in each patient is crucial for effective treatment.

Practitioners should assess individual pathophysiological traits to tailor OSA treatments.

Nose-to-brain (N2B) pathways can address limitations of the subcutaneous route for GLP-1 RAs.

Practitioners should explore N2B pathways as a viable alternative for delivering GLP-1 RAs.

There is no significant change in resting state functional connectivity (RSFC) after the semaglutide intervention compared to the placebo group in the investigated regions of interest (ROIs).

Practitioners can consider that semaglutide does not significantly alter RSFC related to suicidal ideation and behavior in this population.

The change in RSFC between visits did not differ significantly between the groups.

This indicates that semaglutide does not lead to significant changes in RSFC over the study period compared to placebo.

OXT/GLP-1 co-administration increases c-Fos expression in the PVN and supraoptic nucleus.

Increased neuronal activation in specific brain regions may underlie the effects on food intake and body weight.

Amylin and salmon calcitonin target distinct neurons in various brain regions.

Insights into neural targeting can inform obesity treatment strategies.